EZH2 and ovarian neoplasm: In the current study, by inhibiting the activity of the EZH2-binding partner HOTAIR, which is frequently co-expressed in EZH2-overexpressing cancers35, we demonstrate a novel and effective strategy for resensitizing resistant ovarian tumors to platinum.